Initially developed for managing type 2 diabetes, these medications are now recognized for their broader benefits, particularly in promoting healthy aging and longevity
Heres a straightforward breakdown of what sets Mounjaro (tirzepatide) and semaglutide apart
Limited early studies primarily with liraglutide, a GLP-1 receptor agonist suggest that weight loss on GLP-1 therapy may coincide with improvements in semen parameters, such as sperm concentration, motility, and morphology
By targeting two hormones instead of one, tirzepatide, which is the only dual GLP-1/GIP agonist with FDA approval, has shown an even greater ability than other drugs to help patients lose weight
The first GLP-1 analog (exenatide) was derived from the surprising source of Gila monster venom and approved in 2005 ( [3] ) ( [4] ), opening a new era of incretin mimetic therapy